Meg Watson

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. ncbi Burden of cervical cancer in the United States, 1998-2003
    Meg Watson
    Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA
    Cancer 113:2855-64. 2008
  2. ncbi Investment in safe routes to school projects: public health benefits for the larger community
    Margaret Watson
    Oak Ridge Institute for Science and Education Fellow, Division of Cancer Prevention and Control, CDC, 4770 Buford Highway, Mailstop K 55, Atlanta, GA 30341, USA
    Prev Chronic Dis 5:A90. 2008
  3. ncbi Melanoma surveillance in the United States: overview of methods
    Meg Watson
    Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA
    J Am Acad Dermatol 65:S6-16. 2011
  4. ncbi Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: overview of methods
    Meg Watson
    Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA
    Cancer 113:2841-54. 2008
  5. ncbi Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels
    Ahmedin Jemal
    Surveillance Research Program, American Cancer Society, 250 Williams St NW, Atlanta, GA 30303, USA
    J Natl Cancer Inst 105:175-201. 2013
  6. ncbi Update of HPV-associated female genital cancers in the United States, 1999-2004
    Meg Watson
    Epidemiology and Applied Research Branch, Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA
    J Womens Health (Larchmt) 18:1731-8. 2009
  7. ncbi Incidence of in situ and invasive vulvar cancer in the US, 1998-2003
    Mona Saraiya
    Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA
    Cancer 113:2865-72. 2008
  8. ncbi Prevalence of human papillomavirus types in invasive vulvar cancers and vulvar intraepithelial neoplasia 3 in the United States before vaccine introduction
    Julia W Gargano
    Epidemic Intelligence Service, Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Low Genit Tract Dis 16:471-9. 2012
  9. ncbi Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States
    Harrell W Chesson
    Division of STD Prevention, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Vaccine 30:6016-9. 2012
  10. ncbi Cervical carcinoma rates among young females in the United States
    Vicki B Benard
    Epidemiology and Applied Research Branch, Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia and the American Society for Clinical Pathology, Chicago, Illinois
    Obstet Gynecol 120:1117-23. 2012

Detail Information

Publications10

  1. ncbi Burden of cervical cancer in the United States, 1998-2003
    Meg Watson
    Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA
    Cancer 113:2855-64. 2008
    ..This article provides a baseline for monitoring the impact of the HPV vaccine on the burden of cervical cancer over time...
  2. ncbi Investment in safe routes to school projects: public health benefits for the larger community
    Margaret Watson
    Oak Ridge Institute for Science and Education Fellow, Division of Cancer Prevention and Control, CDC, 4770 Buford Highway, Mailstop K 55, Atlanta, GA 30341, USA
    Prev Chronic Dis 5:A90. 2008
    ..The Safe Routes to School (SRTS) program is designed to encourage active and safe transportation for children to school. This report examines the potential broader impact of these programs on communities within 0.5 mile (0.8 km) of schools...
  3. ncbi Melanoma surveillance in the United States: overview of methods
    Meg Watson
    Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA
    J Am Acad Dermatol 65:S6-16. 2011
    ..Although recent reports suggest that melanoma incidence rates have been increasing, these apparent increases could be caused by an increase in reporting and/or screening, and by an actual increase in the occurrence of melanoma...
  4. ncbi Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: overview of methods
    Meg Watson
    Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA
    Cancer 113:2841-54. 2008
    ....
  5. ncbi Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels
    Ahmedin Jemal
    Surveillance Research Program, American Cancer Society, 250 Williams St NW, Atlanta, GA 30303, USA
    J Natl Cancer Inst 105:175-201. 2013
    ..This year's report includes incidence trends for human papillomavirus (HPV)-associated cancers and HPV vaccination (recommended for adolescents aged 11-12 years)...
  6. ncbi Update of HPV-associated female genital cancers in the United States, 1999-2004
    Meg Watson
    Epidemiology and Applied Research Branch, Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA
    J Womens Health (Larchmt) 18:1731-8. 2009
    ..Enhancing current cancer surveillance systems, combined with special studies to collect data on in situ or precancerous lesions of these cancers, will provide important information in determining the potential impact of the HPV vaccine...
  7. ncbi Incidence of in situ and invasive vulvar cancer in the US, 1998-2003
    Mona Saraiya
    Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA
    Cancer 113:2865-72. 2008
    ..To provide a baseline picture before HPV vaccine implementation, the authors described vulvar cancer epidemiology by age, race, ethnicity, and histology in the US...
  8. ncbi Prevalence of human papillomavirus types in invasive vulvar cancers and vulvar intraepithelial neoplasia 3 in the United States before vaccine introduction
    Julia W Gargano
    Epidemic Intelligence Service, Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Low Genit Tract Dis 16:471-9. 2012
    ..The study aimed to determine the baseline prevalence of human papillomavirus (HPV) types in invasive vulvar cancer (IVC) and vulvar intraepithelial neoplasia 3 (VIN 3) cases using data from 7 US cancer registries...
  9. ncbi Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States
    Harrell W Chesson
    Division of STD Prevention, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Vaccine 30:6016-9. 2012
    ..0 billion (12.0%) was for cancer (including $0.4 billion for cervical cancer and $0.3 billion for oropharyngeal cancer), $0.3 billion (3.6%) was for genital warts, and $0.2 billion (2.1%) was for RRP...
  10. ncbi Cervical carcinoma rates among young females in the United States
    Vicki B Benard
    Epidemiology and Applied Research Branch, Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia and the American Society for Clinical Pathology, Chicago, Illinois
    Obstet Gynecol 120:1117-23. 2012
    ..Two federal cancer surveillance systems were used to quantify the burden of invasive cervical carcinoma among women younger than 40 years of age...